High Throughput Screening Market to Witness Steady Growth in the Near Future

 Market growth is driven mainly by factors such as increasing R&D spending by pharmaceutical & biotechnology companies, technological advancements in high-throughput screening market and the availability of government funding & venture capital investments. Emerging markets and growing applications in life sciences research are also factors expected to provide growth opportunities for players in the HTS market.

The global High-Throughput Screening (HTS) Market size is projected to reach USD 26.4 billion by 2025 from USD 15.3  billion in 2020, at a CAGR of 11.5% during the forecast period.

Ask for PDF Brochure:-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=134981950

Market Segmentation: -

The consumables segment accounted for the largest share of the product & services segment in the high-throughput screening market in 2019.

On the basis type ofproduct & service, the high-throughput screening market is broadly segmented into consumables , instruments, services, and software. In 2019, consumables accounted for the largest share of the high-throughput screening market. This can primarily be attributed to the wide use of reagents & assay kits in HTS techniques, increasing pharmaceutical R&D, and rising government funding for life sciences research.

The drug discovery segment accounted for the largest share of the application segment in the high-throughput screening market in 2019. 

Based on application, the high-throughput screening market is categorized into four segments—drug discovery, biochemical screening, life sciences, and other applications. The drug discovery application segment accounted for the largest share of the high-throughput screening market in 2019. The key factor driving this segments growth is the increasing number of clinical trials and rising pharmaceutical R&D expenditure.

Key Market Drivers: –
1 Growing Adoption of Open Innovation Models in Pharmaceutical and Biotechnology Companies
2 Government Funding and Venture Capital Investments
3 Increasing R&D Spending
4 Technological Advancements in the HTS market

Regional Analysis: -

In 2019, Asia Pacific region accounted for the fastest-growing region of the high-throughput screening market. It is also estimated to grow at the highest CAGR in the high-throughput screening market during the forecast period, this is mainly due to factors such as the rising R&D spending, growing public-private partnerships, and increasing government funding are factors driving the growth of the HTS market in this region.

Request for Sample Pages:-  https://www.marketsandmarkets.com/requestsampleNew.asp?id=134981950

Top key Players: -

Some of the prominent players in the high-throughput screening market are Thermo Fisher Scientific Inc. (US),  Agilent Technologies, Inc. (US), Danaher Corporation (US), PerkinElmer, Inc. (US), Tecan Group Ltd. (Switzerland), AXXAM S.p.A. (Italy), Merck KGaA (Germany), Bio-Rad Laboratories, Inc. (US), Promega Corporation (US), Corning Incorporated (US), and Eurofins Scientific (Luxembourg).

Metagenomic Sequencing Market: Continuous technological innovations in NGS platforms

 The Growth in the metagenomic sequencing market is mainly driven by continuous technological innovations in NGS platforms, increasing initiatives and funding from government & private bodies for large-scale sequencing projects, declining costs of genome sequencing, and the significant applications of metagenomics in various fields.

The metagenomic sequencing market is expected to reach USD 4.3 billion by 2027 from USD 1.9 billion in 2022, at a CAGR of 18.4% during the forecast period.

Download PDF Brochure: -https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=60408643

Market Segmentation:

Based on applications, the metagenomic sequencing market is segmented into drug discovery, clinical diagnostics, soil microbiome applications, industrial applications, ecological & environmental applications, veterinary applications, and other applications. The drug discovery segment accounted for the largest share of the market in 2021. The large share of this segment can be attributed to the increasing research activities for novel drug discovery and growing collaborations between market players, academic institutions, and pharmaceutical companies for drug development.

Based on products & services, the metagenomic sequencing market is segmented into reagents & consumables, instruments, services, and analysis & data interpretation solutions. The reagents & consumables segment accounted for the largest share of the market in 2021. Factors such as the development and commercialization of high-quality reagents and kits and the continuous requirement of sequencing reagents by end users are expected to drive the growth of this segment in the market.

Regional Analysis:

The market in the Asia Pacific is expected to register the highest growth rate during the forecast period, primarily due to the increasing financial support from public as well as private agencies, the increasing number of NGS-based research projects, increasing awareness about precision medicine, and the rising prevalence of chronic diseases.

Request Sample Pages: - https://www.marketsandmarkets.com/requestsampleNew.asp?id=60408643

Top Key Players:

Some of the leading players operating in the metagenomic sequencing market are Illumina, Inc. (US), Thermo Fisher Scientific (US), QIAGEN N.V. (Netherlands), PerkinElmer, Inc. (US), and Oxford Nanopore Technologies Plc. (UK).

Pharmaceutical Packaging Equipment Market: High growth in generics & biopharmaceuticals markets

 The growth of the global pharmaceutical packaging equipment market is driven by the rapidly growing generic & biopharmaceutical markets, growth in OTC drug sales, rising need for flexible and integrated packaging equipment, increased offshore manufacturing in the pharmaceuticals market, the introduction of regulatory standards on the packaging, and stringent norms against counterfeiting. However, factors such as the adoption of refurbished packaging equipment and the high cost of packaging equipment are expected to restrain market growth to a certain extent during the forecast period.

The global pharmaceutical packaging equipment market is projected to reach USD 11.9 Billion by 2027 from USD 8.4 Billion in 2022, at a CAGR of 7.2% from 2022 to 2027. 

Download PDF Brochure :-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=19845828

Market Segmentation: - 

The primary packaging equipment segment accounted for the largest share of the global market in 2021. The main function of primary packaging is to restrict climatic, chemical, or biological hazards that cause deterioration. The rising need for the aseptic filling and the sealing of drug molecules into sterile containers and the increasing demand for parenteral vials and prefillable syringes are supporting the growth of this segment.

Based on type, the market is segmented into liquid, solid, semi-solid, and other packaging equipment. In 2021, the liquid packaging equipment segment accounted for the largest share of the pharmaceutical packaging equipment market. The large share of the liquid packaging equipment segment is mainly attributed to the high production of liquid formulations and the increasing incidence of eye and ear disorders across the globe.

Regional Analysis:

Europe is the largest regional market for pharmaceutical packaging equipment with a share in 2021. Growth in the European market is majorly driven by the high pharm aceutical production, increasing demand for flexible packaging equipment by major pharmaceutical manufacturers, and the rising focus on product diversification by companies, which is driving the demand for innovative packaging equipment. Regulatory changes are also compelling pharmaceutical manufacturers to replace their older equipment with new equipment to adhere to the changing standards.

Inquiry Before Buying : - https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=19845828

Top Key Players: -

Prominent players in the pharmaceutical packaging equipment market include Robert Bosch GmbH (Syntegon Technology GmbH) (Germany), IMA S.p.A. (Italy), Körber AG (Germany), Coesia S.p.A (Italy), Marchesini Group S.p.A (Italy), Bausch+Ströbel Maschinefabrik Ilshofen GmbH+Co. KG (Germany), Romaco Group (Germany), Uhlmann Group (Germany), Maquinaria Industries Dara, SL (US) and MULTIVAC Group (Germany).

US Surgical Procedures Market worth 122,881.5 thousand procedures by 2027 - Exclusive Report by MarketsandMarkets™

 "US Surgical Procedures Market by Type (Gastrointestinal, Cardiovascular, Dental, Cosmetic, Urologic, Ophthalmic, Orthopedic, ENT, Gynecologic Surgical Procedures), Channel (Physician Offices, Hospitals, (Inpatient, Outpatient), ASC) - Forecast to 2027", published by MarketsandMarkets™, the US surgical procedures market is projected to reach 122,881.5 thousand procedures by 2027 from 105,814.5 thousand procedures in 2022, at a CAGR of 3.0% during the forecast period.

Browse in-depth TOC on "US Surgical Procedures Market"
20 – Tables
25 – Figures
79 – Pages

Download PDF Brochure-https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=94756744

Scope of the Report:

The study categorizes the US Surgical Procedures Market based on type and channel.

US Surgical Procedures Market, by Type

• Gastrointestinal Surgical Procedures
• Cardiovascular Surgical Procedures
• Dental Surgical Procedures
• Cosmetic Surgical Procedures
• Urologic Surgical Procedures
• Ophthalmic Surgical Procedures
• Orthopedic Surgical Procedures
• ENT Surgical Procedures
• Obstetric/Gynecologic Surgical Procedures
• Other Surgical Procedures

Note: Other surgical procedures include procedures targeting the nervous system, the endocrine system, and the integumentary system.

US Surgical Procedures Market, by Channel

• Physician Offices
• Hospitals
• Inpatient Surgeries
• Outpatient Surgeries
• Ambulatory Surgery Centre

 

The growth of the US surgical procedures market is largely driven by the growing prevalence of chronic diseases, the rising geriatric population, and increased investment in health facilities. On the other hand, stringent regulations and the high cost of medical devices are major restraints in the market.

The emergence of the COVID-19 pandemic has changed the delivery of medical care. The increased pressure due to the growing rate of hospitalization of COVID-19 patients led to the re-profiling of many hospitals and departments for treating patients with COVID-19. Consequently, many elective surgeries were canceled or postponed worldwide to reserve or redirect the available limited capacities and resources (like hospital beds and patient care professionals) toward COVID-19 patient care and to reduce the spread of the virus.

Moreover, from 2019–2020, the procedural volume for all surgeries declined substantially, but it is expected to increase post-pandemic 2021–2022 due to the backlog emerging from this delay. According to a study by Stanford Medicine, after the March 2020 COVID-19 shutdown, nonurgent surgery rates dropped, but within months they bounced back and remained at pre-pandemic levels. There was a 48% decrease in surgical volume during the seven weeks after mid-March when the CMS recommended that hospitals minimize, postpone, or cancel elective surgeries. By July 2020, the nation's hospitals had ramped up surgical operations with improved safety protocols, and surgery rates began to return to their 2019 levels. By the end of the year, the total volume of surgeries was only 10% below the 2019 volume.

Request Sample Pages: -https://www.marketsandmarkets.com/requestsampleNew.asp?id=94756744

In 2021, the dental surgical procedures segment accounted for the largest share of this market.

Based on type, the US surgical procedures market is segmented into gastrointestinal surgical procedures, cardiovascular surgical procedures, dental surgical procedures, cosmetic surgical procedures, urologic surgical procedures, ophthalmic surgical procedures, orthopedic surgical procedures, ENT surgical procedures, obstetric/gynecologic surgical procedures, and other surgical procedures. The share of dental surgical procedures segment can be attributed to the increasing awareness of oral care, increasing prevalence of oral diseases, and rising aging population and the associated teeth loss. Common types of dental surgery include:

Root canal: Root canals are the most common type of dental surgery. According to the School of Dental Medicine (US), more than 15 million root canals are performed every year in the US. According to the American Association of Endodontists, root canals have a success rate of over 95%, and, in most cases, they last a lifetime.

Dental implants: Dental implants replace teeth due to decay, disease, oral cancer, or several causes like smoking or alcoholism.

In 2021, the ambulatory surgery center segment accounted for the largest share of this market.

Based on channel, the US surgical procedures market is segmented into physician offices, hospitals, and ambulatory surgery centers. The ambulatory surgery center segment is estimated to grow at the highest CAGR during the forecast period. The preference for ASCs has risen due to their limited hospitalization time, lower costs than hospital outpatient departments (HOPDs), effective postoperative care, limited risk of disease relapse, and faster patient recovery.

The inpatient surgeries segment accounted for the largest share of the US surgical procedures market for hospitals in 2021.

Hospitals are subsegmented into inpatient surgeries and outpatient surgeries. The inpatient surgeries segment accounted the largest share of the US surgical procedures market for hospitals in 2021. Market growth of this segment is attributed to the preference for robotic-assisted surgery, the surge in the geriatric population, the growing incidence of target conditions (such as cardiovascular diseases, neurological disorders, and traumatic injuries), and the introduction of advanced surgical technologies.

Nuclear Imaging Equipment Market: Growing demand for data integrated imaging systems

 The nuclear imaging equipment market refers to the market for medical devices and equipment used in nuclear medicine. This includes equipment such as single-photon emission computed tomography (SPECT) and positron emission tomography (PET) scanners. The demand for these devices is driven by the increasing prevalence of chronic diseases such as cancer, cardiovascular diseases, and neurological disorders, as well as the growing aging population.

The nuclear imaging equipment market is expected to reach USD 3.4 billion by 2025 from USD 2.6 billion in 2020, at a CAGR of 4.9% during the forecast period.

The growth in Nuclear Imaging Equipment Market is mainly driven by the shift from standalone to hybrid modalities, advances in radiotracers, the increasing focus on personalized medicine, investments through public-private partnerships to modernize diagnostic imaging centers, and the increasing incidence and prevalence of cancer and cardiac ailments. However, the high cost of nuclear imaging equipment is expected to limit the growth of this market.

Download PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=98

Market Segmentation:

Based on product, the nuclear imaging equipment market is segmented into hybrid PET imaging systems, SPECT imaging systems, and planar scintigraphy imaging systems. The SPECT imaging systems segment is further categorized into standalone and hybrid imaging systems. The SPECT imaging systems segment is expected to the largest share in 2019. The large share of this segment can be attributed to high adoption of SPECT imaing systems on account of lower cost as compared to hybrid PET imaging systems,

Based on application, the nuclear imaging equipment market is segmented into oncology, cardiology, neurology, and other applications. The oncology application segment is expected to register the highest CAGR during the forecast period. The major factors contributing to the growth of this segment include the rising incidence and prevalence of cancer across the globe, initiatives taken by public and private organizations to curb the rising cancer prevalence, and the development of advanced systems and radiotracers for oncology.

Based on end user, the nuclear imaging equipment market is segmented into hospitals, imaging centers, academic & research centers, and other end users. Hospitals accounted for the largest share of the global nuclear imaging equipment market in 2019. This can be attributed to factors such as the need to improve the efficiency of diagnostic imaging procedures and the rising number of diagnostic imaging procedures performed in hospitals. 

Regional Analysis:

North America, Europe, Asia Pacific, and the Rest of the World (RoW) are the regions considered for geographic analysis of the global nuclear imaging equipment market study. North America is expected to account for the largest share of the global nuclear imaging equipment market. The large share of North America is attributed to the increasing geriatric population, high incidence/prevalence of various diseases, a large number of diagnostic imaging centers/procedures, increasing awareness about the benefits of early disease diagnosis, and the rapid adoption of technologically advanced imaging systems in this region.

Inquiry Before Buying:- https://www.marketsandmarkets.com/Enquiry_Before_BuyingNew.asp?id=98

Top Key Players:

The prominent players in the global nuclear imaging equipment market include are Siemens Healthineers (Germany), Philips Healthcare (Netherlands), and GE Healthcare (US). The other players in the market include Toshiba Medical Systems Corporation (Japan), Neusoft Medical Systems Co., Ltd. (China), Mediso Medical Imaging Systems Ltd. (Hungary), Digirad Corporation (US), CMR Naviscan Corporation (US), SurgicEye GmbH (Germany), and DDD Diagnostics (Denmark).

 

Animal Wound Care Market: Growing prevalence of animal diseases

 Animal Wound Care Market is projected to grow from USD 1.2 billion in 2022 to USD 1.7 billion by 2027, at a CAGR of 7.3% from 2022 to 2027, according to a new report by MarketsandMarkets™. The growth in this market is driven by rising demand for animal food products, increasing companion animal market, and surging veterinary healthcare expenditure. However, an upsurge in pet care expenditures and the dearth of vet practitioners in developing markets are impeding the market's growth.

Download PDF Brochure: 
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=253831778

Browse in-depth TOC on "Animal Wound Care Market" 
245 – Tables 
46 – Figures 
267 – Pages

In this report, the animal wound care market is segmented on the basis of product, animal type, end users and region.

"Companion animals defined for the largest share in the animal wound care market by animals"

In 2021, companion animals for a larger share of the global market. The growth of this segment can be attributed to the growing companion animal population, increasing pet care expenditure, the rising number of sports horses, and surging demand for pet insurance across the world.

"Veterinary hospitals and clinics accounted for the largest share in the animal wound care market by end user"

On the basis of end users, the market is segmented into veterinary hospitals and clinics and home care settings. The large share of this segment can be attributed to increasing companion animal population and rising pet care expenditure in emerging regions.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=253831778

"Based on Region, North America holds the largest share in the animal wound care market"

On the basis of region, the animal wound care market is segmented into North America, Europe, Asia Pacific, Latin America, and Middle East Africa. North America segment accounted for the largest share of the market in 2021 due to major players availability and advanced healthcare infrastructure.

Key Market Players:

The prominent players in the global animal wound care market are Medtronic PLC (Ireland), Elanco Animal Health (US), Virbac (France), B. Braun Melsungen AG (Germany), Dechra Pharmaceuticals (UK), Neogen Corporation (US), Jorgen Kruuse A/S (Denmark), Ethicon, Inc. (US), Sonoma Pharmaceuticals Inc. (US), Prima-Vet Inc. (US), Smith & Nephew PLC (UK), Jazz Medical, LLC (Ireland), Kericure Inc. (US), etc.

The Growing Importance of 3D Imaging in Medical Image Analysis Software

 Introduction:

Medical image analysis software is a type of software that is used to analyze medical images. These images may be generated by various medical imaging modalities such as X-ray, CT (computed tomography), MRI (magnetic resonance imaging), ultrasound, PET (positron emission tomography), and SPECT (single photon emission computed tomography).

Medical image analysis software helps medical professionals to diagnose and treat various diseases and conditions by providing them with quantitative and qualitative information about the images. This software is often used to assist with the detection and diagnosis of cancer, heart disease, neurological disorders, and musculoskeletal injuries, among other conditions.

Global Medical Image Analysis Software Market Overview

“Medical Image Analysis Software Market by Type (Integrated), Images (2D, 3D, 4D), Modality (CT, MRI, PET, Ultrasound), Application (Orthopedic, Oncology, Neurology, Mammography, Dental), End User (Hospital, Diagnostic Center) - Global Forecasts to 2027”, published by MarketsandMarkets™, is projected to reach USD 4.5 billion by 2027 from USD 3.2 billion in 2022, at a CAGR of 7.8%.

Browse in-depth TOC on “Medical Image Analysis Software Market”
342 – Tables
56 – Figures
361 – Pages

Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=846

While budgetary constraints are expected to restraint the global medical image analysis software market during the forecast period, increasing government investments in the field, rising chronic disease-ridden population, and advancements in related technologies are some of the factors set to drive the market.

In this report, the medical image analysis software market is classified into six segments—type, image type, modality, application, end user, and region.

Market Segmentation: -

“In 2021, the integrated software segment accounted for the largest market share.”

The integrated software segment occupied a larger share of 61.8% of the medical image analysis software market in 2021. The segment is expected to exhibit the highest CAGR of 8.6% during the forecast period. The large share of this segment can be attributed to the benefits of integrated software, such as cost-effectiveness, centralized data storage, and access to live data for multiple users to process, are also expected to support the growth of this segment.

“By image type, the 3D imaging segment was the larger market share in 2021.”

The 3D imaging segment accounted for the larger share of the medical image analysis software market in 2021. This segment is expected to maintain its leading position throughout the forecast period owing to technological advancements in 3D imaging technology, such as artificial intelligence and machine learning, enabling efficient and accurate real-time visualization of the human body, thereby eliminating distortion in procedures.

“The tomography segment accounted for the largest market share in 2021.”

The tomography segment accounted for the largest share of 46.5% of the medical image analysis software market in 2021. This segment is projected to reach USD 2,066.7 million by 2027 from USD 1,459.1 billion in 2022, at a CAGR of 7.2% during the forecast period. Technological advancements like 4D imaging systems and software, artificial intelligence, and hybrid imaging modalities; software modifications; and the growing number of CT scanner installations across the globe are expected to drive the tomography segment during the forecast period.

Regional Analysis: -

“In 2021, North America was the region with the largest market share in the medical image analysis software market “

The medical image analysis software market is segmented into five major regions, namely, North America, Europe, Asia Pacific (APAC), Latin America, and the Middle East & Africa.

North America accounted for the largest share of the medical image analysis software market in 2021. Favorable government initiatives to support the adoption of healthcare IT, and the presence of key market players are favorable factors for market growth in this region.
Asia Pacific was the fastest growing region, which can be attributed to the growing medical imaging research and increasing adoption of medical image analysis software by healthcare professionals in the region.

Request Sample Pages: 
https://www.marketsandmarkets.com/requestsampleNew.asp?id=846

Recent Developments

·         In March 2022, Koninklijke Philips N.V. (Netherlands) launched Cloud-enabled Enterprise Imaging Informatics and Analytics Solutions, namely, HealthSuite Interoperability and Enterprise Performance Analytics – PerformanceBridge, to meet diverse workflow needs across the imaging enterprise.

·         In February 2022, IBM (US) acquired Neudesic, LLC (US) which was aimed at expanding IBM’s portfolio of hybrid multi-cloud services and further advancing the company’s hybrid cloud and AI strategy.

·         In February 2022, Siemens Healthineers (Germany) collaborated with Universal Medical Imaging (US) to help primary healthcare institutions in China improve the efficiency of their image screening and disease diagnosis using advanced imaging diagnostic equipment and remote scanning assistant tools from Siemens Healthineers and nationwide medical imaging experts at Universal Medical Imaging.

·         In January 2022, IBM (US) acquired ENVIZI (Australia) which was aimed at building on IBM's growing investments in AI-powered software.

Key players offering Medical Image Analysis Software Products in this market include:

• GE Healthcare (US),
• Koninklijke Philips N.V. (Netherlands),
• Siemens Healthineers (Germany),
• Canon Inc. (Japan),
• Image Analysis, Ltd. (UK), and
• ScienceSoft USA Corporation (US).

These companies adopted strategies such as service launches, business expansions, agreements, partnerships, collaborations, and acquisitions to strengthen their presence in the medical image analysis software market.

Conclusion: -

The market for medical image analysis software is rapidly growing due to the increasing demand for advanced medical imaging technologies in healthcare. The market is driven by factors such as the rising prevalence of chronic diseases, the need for efficient and accurate diagnosis, and the development of innovative imaging modalities. Overall, the market for medical image analysis software is a dynamic and rapidly evolving space, with significant opportunities for growth and innovation.

 

 

What are the recent trends affecting the Cell Analysis Market?

 Increase in the number of discovery research studies serves as one of the key driving factors of the cell analysis market. The role of cell analysis in drug discovery has expanded significantly over the years, with new technologies being introduced in the market that generate accurate results while minimizing the time required. This is also supplemented by technological advancements in the field of molecular biology, cell biology, and genomics.

The global Cell Analysis Market is projected to reach USD 28.6 billion by 2027 from USD 17.7 billion in 2022, at a CAGR of 10.1% during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=157543946

Market Segmentation:

Based on product & service, the global market is segmented into reagents & consumables, instruments, accessories, software, and services. Cell analysis software serves as an attractive market space attributed to the advancements made in cell analysis, specially in the areas of flow cytometry and single-cell analysis. This has led to an increase in the number of emerging companies entering this market space. As a result, the software segment is projected to register the highest CAGR during the forecast period.

Based on technique, the global market is segmented into flow cytometry, PCR, cell microarrays, microscopy, spectrophotometry, high-content screening, and other techniques. The flow cytometry segment accounted for the largest market share of in 2021. The flow cytometry technique has gained significant traction across different analysis processes, including single-cell analysis. This technique is able to perform simultaneous measurement and analysis of distinct characteristics of single-cell particles when they flow in a fluid stream of a light beam.

Based on process, the global market is segmented into cell identification, cell viability, cell signaling pathway/signal transduction, cell proliferation, cell counting & quality control, cell interaction, cell structure study, target identification & validation, and single-cell analysis. Cell analysis applications are expected to broaden across the fields of therapeutics, research, and diagnostics attributed to the advent of single-cell analysis. This has rendered this segment with the fastest growth rate during the forecast period. Additionally, single-cell analysis serves as a powerful tool to assess individual cells at multiple parameters, in a heterogeneous cell population.

On the basis of end users, the market is segmented into pharmaceutical & biotechnology companies, hospitals & clinical testing laboratories, academic & research institutes, and other end users. The demand for cell analysis products is set to elevate across in-house diagnostic and research centers, in-house pathology centers, and reference laboratories; collectively contributing to the fastest growth rate of hospitals & clinical testing laboratories during the forecast period. The development of highly specialized and complex cell-based assays is expected to supplement this growth.

Regional Analysis:

The global market is segmented into North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. The Asia Pacific market is estimated to grow at the highest CAGR during the forecast period. Rapid increase in the pharmaceutical & biopharmaceutical industries coupled with affordable with cell analysis services are the key contributing factors to the regional growth.

Request Sample Pages:  -https://www.marketsandmarkets.com/requestsampleNew.asp?id=157543946

Top key Players :

The cell analysis market is fragmented in nature with prominent players operating in this market such as Danaher (US), Thermo Fisher Scientific (US), Becton, Dickinson and Company (US), General Electric (US), Merck KGaA (US), Agilent Technologies (US), Olympus Corporation (Japan), Miltenyi Biotec (US), Bio-Rad Laboratories (US), BioStatus Limited (UK), Fluidigm Corporation (US), NanoCellect Biomedical (US), Cell Biolabs (US), Creative Bioarray (US), Meiji Techno (US), Promega Corporation (US), PerkinElmer (US), Tecan Trading AG (Switzerland), CELLINK (US), QIAGEN (Germany), Corning Incorporated (US), 10x Genomics (US), and Illumina (US).